Beauty Health (SKIN) Stock Forecast & Price Target

$3.15
-0.07 (-2.17%)
(As of 04/24/2024 ET)

Beauty Health Consensus Analyst Rating and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Analysts' Consensus Rating

Reduce
Based on 12 Analyst Ratings

Analysts' Consensus Price Target

$6.50
106.35% Upside
High Forecast$23.00
Average Forecast$6.50
Low Forecast$2.50
TypeCurrent Forecast
4/26/23 to 4/25/24
1 Month Ago
3/27/23 to 3/26/24
3 Months Ago
1/26/23 to 1/26/24
1 Year Ago
4/26/22 to 4/26/23
Consensus Rating
Reduce
Reduce
Hold
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
2 Buy rating(s)
2 Buy rating(s)
3 Buy rating(s)
6 Buy rating(s)
Hold
7 Hold rating(s)
7 Hold rating(s)
8 Hold rating(s)
2 Hold rating(s)
Sell
3 Sell rating(s)
3 Sell rating(s)
3 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$6.50$6.50$8.38$19.43
Predicted Upside106.35% Upside65.14% Upside53.41% Upside68.40% Upside
Get Beauty Health Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for SKIN and its competitors with MarketBeat's FREE daily newsletter.

SKIN Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

SKIN Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Beauty Health Stock vs. The Competition

TypeBeauty HealthMedical CompaniesS&P 500
Consensus Rating Score
1.92
2.68
2.49
Consensus RatingReduceModerate BuyHold
Predicted Upside106.35% Upside989.49% Upside9.98% Upside
News Sentiment RatingPositive News
Neutral News
Positive News

Recent Analyst Ratings and Stock Forecasts

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/15/2024DA Davidson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy$5.00+36.61%
3/14/2024Canaccord Genuity Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetHold ➝ Hold$3.00 ➝ $4.00+9.29%
3/13/2024TD Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetMarket Perform ➝ Market Perform$2.50 ➝ $4.00+9.29%
3/13/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingHold ➝ Hold$3.00 ➝ $4.00+9.29%
3/13/2024Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingUnderweight ➝ Underweight$2.00 ➝ $3.00-18.03%
11/15/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/14/2023JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeNeutral ➝ Underweight
11/14/2023Benchmark
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
11/14/2023Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeMarket Perform ➝ Underperform
11/14/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Market Perform
9/19/2023Imperial Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Thursday at 02:10 AM ET.

SKIN Price Target - Frequently Asked Questions

What is Beauty Health's consensus rating and price target?

According to the issued ratings of 12 analysts in the last year, the consensus rating for Beauty Health stock is Reduce based on the current 3 sell ratings, 7 hold ratings and 2 buy ratings for SKIN. The average twelve-month price prediction for Beauty Health is $6.50 with a high price target of $23.00 and a low price target of $2.50. Learn more on SKIN's analyst rating history.

Do Wall Street analysts like Beauty Health more than its competitors?

Analysts like Beauty Health less than other Medical companies. The consensus rating for Beauty Health is Reduce while the average consensus rating for medical companies is Moderate Buy. Learn more on how SKIN compares to other companies.

Does Beauty Health's stock price have much upside?

According to analysts, Beauty Health's stock has a predicted upside of 65.14% based on their 12-month stock forecasts.

What analysts cover Beauty Health?

Beauty Health has been rated by Canaccord Genuity Group, DA Davidson, Piper Sandler, Stifel Nicolaus, and TD Cowen in the past 90 days.


Stock Ratings Reports and Tools

This page (NASDAQ:SKIN) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners